Manufacturing ATMPs – moving from approvable to commercial success

Registration is now open for this conference organised by the Future Targeted Healthcare Manufacturing Hub, in partnership with the Knowledge Transfer Network (KTN), to be held on 18th September at Woburn House Conference Centre in London. The meeting will focus on the current UK innovation landscape for advanced therapies, in support of enabling gene and cell therapy products to go from approvable to commercially successful. We will also hear about translational research projects in support of manufacturing readiness, in addition to a future looking session regarding key challenges from clinical, regulatory and skills perspectives. The Hub and KTN partner to deliver this meeting enabling industry and academia engagement and collaboration, and showcasing of the relevant translational research being undertaken by the Hub in collaboration with industry.

We are expecting about 100 delegates on the day from the wider sector. The event is free to attend for the community. The agenda will be published soon.

Call for Posters
There will be a chance for researchers from both academia and industry to share and present relevant posters. Please note your interest on registration and use the free text box to indicate the title (or short descriptor).

Further information
Please note, places for this event are limited and if the meeting is oversubscribed, places will be prioritised for those who are technical practitioners in the sector. We may need to limit number of representatives from any one organisation.
For any queries please contact Marcel Kuiper